MedPath

INNOHEP

INNOHEP

Approved
DIN Number

02229515

Drug Class

Human

Market Date

Feb 28, 1997

Company
HC

LEO Pharma Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229515
AIG Number0124929003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB10 TINZAPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

TINZAPARIN SODIUMActive
Strength: 20000 UNIT / ML
Monograph: TINZAPARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.